Table 1.
Patient Characteristics
| All Patients | Metastatic | Localized | |
|---|---|---|---|
| Patient Characteristics | N (%) | N (%) | N (%) |
| All | |||
| 186 (100%) | 122 (100%) | 64 (100%) | |
| Age | |||
| <50 | 46 (25%) | 32 (26%) | 14 (22%) |
| 50–69 | 115 (62%) | 81 (66%) | 34 (53%) |
| ≥70 | 25 (13%) | 9 (8%) | 16 (25%) |
| Gender | |||
| Female | 68 (37%) | 45 (37%) | 23 (36%) |
| Male | 118 (63%) | 77 (63%) | 41 (64%) |
| Race/Ethnicity | |||
| Black | 9 (5%) | 5 (4%) | 4 (6%) |
| Hispanic | 28 (15%) | 15 (12%) | 13 (20%) |
| White | 142 (76%) | 97 (80%) | 45 (71%) |
| Other | 7 (4%) | 5 (4%) | 2 (3%) |
| Pathologic Tumor Stage | |||
| T1 and T2 | 35 (19%) | 23 (19%) | 12 (19%) |
| T3 | 119 (63%) | 84 (69%) | 35 (55%) |
| T4 | 29 (16%) | 14 (11%) | 15 (23%) |
| Unknown | 3 (2%) | 1 (1%) | 2 (3%) |
| Clinical N and M Stage | |||
| N0M0 | 64 (34%) | 0 (0%) | 64 (100%) |
| N0M1 | 93 (50%) | 93 (76%) | 0 (0%) |
| N1M0 | 16 (9%) | 16 (13%) | 0 (0%) |
| N1M1 | 13 (7%) | 13 (11%) | 0 (0%) |
| Histology | |||
| Clear Cell | 136 (73%) | 87 (71%) | 49 (77%) |
| Other | 50 (27%) | 35 (29%) | 15 (23%) |
| Lymphovascular Invasion | |||
| Yes | 42 (23%) | 29 (24%) | 13 (20%) |
| No | 142 (76%) | 92 (75%) | 50 (78%) |
| Unknown | 2 (1%) | 1 (1%) | 1 (2%) |
| Necrosis | |||
| Yes | 86 (46%) | 62 (51%) | 24 (38%) |
| No Unknown |
97 (52%) 3 (2%) |
58 (47%) 2 (2%) |
39 (61%) 1 (1%) |
| Presurgical Systemic Therapy | |||
| Yes No |
24 (13%) 162 (87%) |
24 (20%) 98 (80%) |
0 64 (100%) |
| Percentage sarcomatoid – median (IQR) | |||
| N=186 | 25 (5, 60) | 30 (10, 60) | 17.5 (5, 50) |
| Tumor size in cm – median (IQR) | |||
| N=168 | 10 (8, 13.5) | 10 (8.25, 13.55) | 10 (8, 12.5) |
IQR = InterQuartile Range